National Policy & Advocacy Summit on Biologics
10:00 am – Welcome/Opening Remarks
- David Charles, MD, Founder, Alliance for Patient Access
10:05 am – Emerging Biologics Landscape
- Chad Pettit, Executive Director, Marketing, Amgen
- Wesley Mizutani, MD, Rheumatologist, Optum Medical Group
- Philip Schneider, FASHP, FFIP, Alliance for Safe Biologic Medicines
- Moderator: David Charles, MD, Founder, Alliance for Patient Access
10:35 am – Biologics in Oncology
- Kathy Oubre, Board of Directors, Community Oncology Alliance
- Sanjay Juneja, MD, Chief of Oncology, Baton Rouge General Hospital
- Claire Saxton, Vice President, Patient Experience, Cancer Support Community
- Moderator: Dennis Cryer, MD, Co-convener, Biologics Prescribers Collaborative
11:05 am – Disparities in Health Care
- Michelle Winokur, DrPH, Executive Director, Institute for Patient Access
- Uma Menon, MD, Chief of Neurology, Morehouse School of Medicine
- Kita Hardy, Patient Ambassador, Color of Crohn’s and Chronic Illness
- Moderator: Josie Cooper, Executive Director, Alliance for Patient Access
11:35 am – Lunch
11:55 am – Using Social Media to Empower Patients
- Sanjay Juneja, MD, Member, White House Leaders in Health Care Social Media Roundtable
12:25 pm – Payers and Policy
- Anna Hyde, Vice President, Advocacy and Access, Arthritis Foundation
- Quardricos Driskell, Vice President, Public Policy and Government Affairs, Autoimmune Association
- Brian Henderson, Director, State Government Affairs, Coalition of State Rheumatology Organizations
- Leslie Narramore, Director of Regulatory Affairs, American Gastroenterological Association
- Moderator: Gavin Clingham, Director of Public Policy, Alliance for Patient Access
1:10 pm – Advocacy in Action
- Ryan Gough, Executive Director, Partnership to Advance Cardiovascular Health
- Sara van Geertruyden, Executive Director, Partnership to Improve Patient Care
- Josie Cooper, Executive Director, Alliance for Patient Access
- Moderator: Amanda Conschafter, Senior Vice President, Strategic Communications, Woodberry Associates
1:50 pm – Closing Remarks
- Josie Cooper, Executive Director, Alliance for Patient Access
David Charles, MD
Founder | Alliance for Patient Access
Dr. David Charles is Chairman of the Alliance for Patient Access and a practicing neurologist in Nashville, Tennessee. Dr. Charles is a national leader in movement disorders research and is past chairman of the Public Policy Committee for the American Neurological Association and Legislative Affairs committee of the American Academy of Neurology. He is a fellow of the American Academy of Neurology and American Neurological Association and past Board member of the United Council of Neurologic Subspecialties, and Past-President of the Tennessee Academy of Neurology. He is currently leading the only clinical trial approved by the United States Food and Drug Administration to test deep brain stimulation in people with early stage Parkinson’s disease. Dr. Charles took leave from his practice in 1998 and spent a year on the staff of the U.S. Senate Subcommittee for Public Health and Safety, where he served as a health policy advisor. Following this experience in Washington, Dr. Charles conducted Parkinson’s disease research in France as a Fulbright Senior Scholar.
Director, Public Policy | Alliance for Patient Access
Gavin Clingham is Director of Public Policy for the Alliance for Patient Access, advising on federal and state policies that impact patient access to health care.
With more than two decades of public policy advocacy experience, Gavin brings a comprehensive understanding of the legislative and regulatory process, having served as Legislative Director for a senior Member of the US House Committee on Appropriations. In his role with AfPA, he engages with federal agencies including CMS and FDA, the US Congress and various state legislatures to ensure the health care providers perspective is considered as access policies are developed and implemented.
Gavin received his Juris Doctor degree from the Boston University School of Law, graduated from The Catholic University of America and is a member of the bar of the Commonwealth of Massachusetts. A lifelong Red Sox fan, he lives in Maryland.
Senior Vice President, Strategic Communications | Woodberry Associates
Amanda Conschafter brings more than a decade of experience in communications, advocacy education and writing training. Ms. Conschafter has provided writing and editing services on behalf of Fortune 500 companies, industry leaders, government contractors, and nonprofits dedicated to education, veterans employment and health policy. She has led writing tutorials and workshops in both academic and business settings.
Ms. Conschafter also served on the legislative staff of Senator Lindsey Graham, where she communicated the senator’s policy positions on education, the judiciary and entitlement programs. Ms. Conschafter holds a B.A. summa cum laude in English and an M.A.T. in English Education from Converse College.
Executive Director | Alliance for Patient Access
Josie Cooper serves as executive director of the Alliance for Patient Access. At AfPA, Ms. Cooper has worked in stakeholder and clinician mobilization, developing policy and educational strategies to improve patient access to care.
Ms. Cooper has a background in communications, research, grassroots organization and campaign politics. Ms. Cooper has worked at the state and national level advising political campaigns and public affairs clients on supporter and stakeholder mobilization. She has worked on major races across the country, from presidential campaigns to Senate and congressional races. Prior to joining AfPA, Ms. Cooper worked for a DC-based consulting firm and for a trade association representing biotechnology companies.
Dennis R. Cryer, MD
Co-Convener | Biologics Prescribers Collaborative
Dr. Dennis R. Cryer is a co-founder and serves as Physician Co-Convener of the Biologics Prescribers Collaborative. An alumnus of Johns Hopkins University and the Medical Scientist Training Program at Albert Einstein College of Medicine of Yeshiva University, Dr. Cryer has an expansive career: in academia on the research and clinical faculty of the University of Pennsylvania School of Medicine, and 20 years in the pharmaceutical industry at Bristol-Myers Squibb, ultimately as vice president of external medical affairs serving as external liaison for advocacy and quality across therapeutic areas. Dr. Cryer played a leadership role in the clinical research, development and launch of two blockbuster drugs in the cardiometabolic space. Dr. Cryer is a member of numerous scientific organizations including American Association of Clinical Endocrinologists, Association of Black Cardiologists, American Diabetes Association, American Heart Association (former Chair of the Pharmaceutical Roundtable), American Society of Human Genetics, American Society of Hypertension (former Chair, Corporate Affairs Committee), the Endocrine Society, and the National Lipid Association. Dr. Cryer is the Chief Medical Officer of CryerHealth, a Washington, DC based patient-centric healthcare consultancy. In addition, he currently serves as Treasurer on the Board of Directors of the Friends of the National Library of Medicine and the Boards of Directors of the Association of Black Cardiologists, the Asthma and Allergy Foundation of America, and the Global Liver Institute.
Vice President of Public Policy & Government Affairs | Autoimmune Association
Quardricos Driskell is Vice President of Public Policy & Government Affairs for the Autoimmune Association, a global organization dedicated to autoimmune awareness, advocacy, education, and research. Driskell spearheads the Autoimmune Association’s public policy efforts to champion patient-first policies at the federal and state levels, handling legislative and regulatory issues while uniting stakeholders across the healthcare ecosystem to protect and improve key policies on behalf of people impacted by autoimmune and immune-mediated diseases. Most notably, Driskell leads the 50+ members of the National Coalition of Autoimmune Patient Groups to protect and improve key policies on behalf of people impacted by autoimmune diseases. He leads the Autoimmune Association’s flagship advocacy program, Let My Doctor’s Decide, a national partnership of healthcare organizations working to support a simple goal: treatment decisions should always be made by patients and trusted healthcare professionals. Driskell is a graduate of Morehouse College, Harvard University, and The George Washington University and serves as an Adjunct Professor in Legislative Affairs at The George Washington University Graduate School of Political Management.
Executive Director | Partnership to Advance Cardiovascular Health
Ryan is the Executive Director of the Partnership to Advance Cardiovascular Health, where he regularly convenes influential stakeholders to address access barriers to appropriate cardiovascular care and improve awareness about cardiovascular disease. Ryan’s background spans a decade in public policy advocacy and campaign politics. He now focuses on helping PACH and other organizations make change in creative and compelling ways.
Patient Ambassador | Color of Crohn’s and Chronic Illness
Kita Hardy was diagnosed with Crohn’s disease on August 13,2016. After many years of being turned away and the countless misdiagnoses, it was in the year of 2016 she began to get an official understanding as to why she was ill and the cause. The many ER visits were taking a toll on her life. As a single mom of 4, at the time of her diagnosis, her children were young and her illness impacted a majority of their childhood.
Director, State Government Affairs | Coalition of State Rheumatology Organizations
Brian Henderson manages state government affairs on behalf of the Coalition of State Rheumatology Organizations where he works closely on utilization management, pharmacy benefit manager, and prescription drug policy across the country. He previously served as Chair of the State Access to Innovative Medicines Coalition and currently serves on the Coalition’s board.
Vice President of Advocacy and Access | Arthritis Foundation
Anna Hyde is the Vice President of Advocacy and Access at the Arthritis Foundation. She oversees both the federal and state legislative programs, in addition to grassroots engagement. Her focus is to raise the visibility of arthritis as a public health priority, build support for federal and state legislation that ensures access to affordable, high-quality health care, and enhance patient engagement in the policy-making process. Anna previously served as Senior Director of Advocacy and Access, managing the federal affairs portfolio and overseeing the state advocacy team.
Prior to joining the Arthritis Foundation in 2014, Anna worked as Senior Manager for Federal Affairs at the American Congress of Obstetricians and Gynecologists, where she managed a portfolio of issues including appropriations, physician workforce, and health IT. She began her health policy career as a Congressional Fellow for Energy and Commerce Committee members, where she drafted legislation and staffed Committee activities. Anna received a BA in History from Southern Methodist University, and taught junior high and high school history before moving to Washington D.C. in 2007 to pursue an MA in Political Science from American University.
Sanjay Juneja, MD
Chief of Oncology Service | Baton Rouge General Hospital
Dr. Sanjay Juneja is a triple board certified Hematologist & Medical Oncologist serving as Chief of Oncology Service at Baton Rouge General Hospital, and a social & news media personality known as ‘TheOncDoc‘ with over half a million followers. He is an active participant for the White House Healthcare Leaders in Social Media Roundtable and national speaker. Dr. Juneja is the host of an innovative podcast called ‘Target: Cancer’ with distinguished academicians and celebrities around the country, and been featured in several articles including The Washington Post and guested on dozens of acclaimed podcasts and regional news channels (PBS, CBS, NBC, NPR). He is a Business Report’s 40 under 40 recipient from his hometown of Baton Rouge, where he partners with the LA Department of Health and Mayor’s office to optimize healthcare access and outreach. Dr. Juneja currently practices in his beloved hometown of Baton Rouge, Louisiana with his wife Dr. Lauren and their three wild boys.
Uma Menon, MD, MBA
Chief of Neurology & Neurology Residency Program Director | Morehouse School of Medicine
Dr. Uma Menon is an Associate Professor and Chief of Neurology at Morehouse School of Medicine, Atlanta,GA.
Dr. Menon completed her medical training in India, followed by residencies in Internal Medicine (Jamaica, West Indies) and Neurology (Louisiana State University Health Sciences Center, Shreveport); and Fellowships in Neurophysiology (Cleveland Clinic, Ohio) and Epilepsy (Yale University). She also holds an MBA in Healthcare from George Washington University.
Dr. Menon was the Neurology Residency program director at Tulane University, New Orleans (2010-2013) and has worked at George Washington University, Washington, DC, and at Ochsner Medical Center, New Orleans.
Dr. Menon has ‘Fellow’ status with the American Epilepsy Society (2017), American Clinical Neurophysiology Society (2017) American Academy of Neurology (2022) and American Neurological Association (2022).
Dr. Menon is the current Chair of the Education section of IDEAS (Inclusion, Diversity, Equity, Anti-Racism and Social Justice) taskforce of the American Neurological Association and Vice- Chair of Ethics section of the American Academy of Neurology. She also volunteers in committees of several national and international professional societies and epilepsy patient support groups.
Dr. Menon has been involved in teaching throughout her career and has published extensively and presented at several national/international meetings. She is an ardent patient and physician advocate and routinely participates in educational forums for professionals, patients and general public.
Dr. Menon’s latest achievement has been to start a Neurology Residency training program at Morehouse School of Medicine (accredited 6/2022) as she continues her work on ethics, advocacy, equity and anti-racism in Neurology and medicine.
Wesley Mizutani, MD, MBA
Rheumatologist | Optum Medical Group
Wesley Mizutani, MD, is a practicing rheumatologist for over 30 years in a group practice setting. He currently serves a lead rheumatologist for Optum Medical Group California. Dr. Mizutani built a successful clinical trials unit for healthcare partners and participated in over 75 clinical trials. He continues to serve as California Chairman of the California Arthritis Foundation Advocacy Council and formerly served on the Arthritis Foundation National Advocacy Committee.
Director of Regulatory Affairs | American Gastroenterological Association
Leslie Narramore is the director of regulatory affairs at the American Gastroenterological Association where she also oversees coding, coverage and reimbursement issues. She graduated from the George Washington University with a masters of public administration and has over 20 years’ experience in the healthcare field. She has held positions and consulting engagements in a variety of aspects of physician practice professional affairs.
CEO | Pontchartrain Cancer Center
Kathy Oubre is the CEO of Pontchartrain Cancer Center in Louisiana.
Kathy is a board member of the Community Oncology Alliance and chairs the Biosimilars committee and serves on their Government Affairs committee. She also serves on the International Oncology Network Panel as well as their government affairs committee. Kathy chairs the NCODA Oncology Institute. She also serves on the Strategic Advisory committee and Leadership Council for Flatiron Health. Kathy is a member of ACCC and serves on their Oral Oncoloytics Advisory committee. Kathy also serves on the editorial boards for The Center for Biosimilars and the Journal of Evidence-Based Managed Care.
Executive Director, Marketing | Amgen
As Executive Director, Marketing for Amgen’s Biosimilars Business Unit, Chad Pettit leads the Global Biosimilars Commercial Team in developing global launch strategy for Amgen’s portfolio biosimilar medicines. With his global experience, Chad is recognized as an expert on biosimilar commercialization, market access for biosimilars, and the policy measures required to facilitate cost savings for patients and the health care system over the long run.
Chad received his MBA from the University of California Los Angeles, Anderson School of Management, and holds a B.S. in Chemical Engineering from the University of California Davis. In his spare time, he provides leadership and service within the community, enjoys the outdoors, and spends time with his wife Amy and four children.
Vice President, Patient Experience | Cancer Support Community
Claire’s current role at the Cancer Support Community (CSC) focuses on sharing CSC’s patient insights externally and ensuring the patient experience remains central to all that CSC does. Prior to becoming VP of Patient Experience, Claire led CSC’s national patient education and outreach efforts for 5 years. The award-winning Frankly Speaking About Cancer education programs were co-created with cancer patients & caregivers. Programs were culturally-adapted to meet the needs of specific populations and speakers of multiple languages and produced in a variety of print, digital, and in-person formats.
Claire came to CSC from the Urology Care Foundation, where she managed national patient education programs and disease awareness campaigns with partners including the National Football League. As Executive Director of the Bladder Cancer Advocacy Network, Claire developed the first National Bladder Cancer Awareness Day. While the Executive Director of the Breast Cancer Resource Center in Austin, Texas, she doubled their patient advocacy and outreach programs. Claire began her work in health advocacy while part of the team that opened the National Domestic Violence Hotline in 1996.
Claire holds an MBA from the University of Oregon and an undergraduate degree from Rice University.
Philip J. Schneider, MS, FASHP
Professor, College of Pharmacy | The Ohio State University
Philip J. Schneider is founder and principal of MediHealthInsight that provides consultation to the industry and others on matters related to improving the use of medicines including the application of new technologies in healthcare.
He is also Chair of the Alliance for Safe Biologic Medicines (ASBM) International Advisory Board. ASBM serves as an authoritative resource center of information for the public, and the healthcare and health policy communities on the issues related to biologic medications.
Professor Schneider holds a faculty appointment as Professor at The Ohio State University College of Pharmacy.
Sara van Geertruyden
Executive Director | Partnership to Improve Patient Care
Sara Traigle van Geertruyden is the Executive Director of the Partnership to Improve Patient Care (PIPC), a coalition chaired by former Congressman Tony Coelho, original author of the Americans with Disabilities Act. Sara joined PIPC in January 2011. Her work is focused on policies to advance a patient-centered health system, from patient engagement in research to driving outcomes that matter to patients in healthcare payment and delivery.
Michelle Winokur, DrPH
Executive Director | Institute for Patient Access
Michelle Winokur serves as Executive Director of the Institute for Patient Access where she leads the development of the organization’s educational content, policy blog, data analysis projects and medical education.
Prior to working with IfPA, Michelle developed educational content for health care clients as a member of the communications team at a DC-based public affairs firm. Before that, she spent more than a decade in public service including executive roles in the offices of Florida’s governor and chief financial officer as well as at the Agency for Health Care Administration and the Department of Health. She also worked for several years as a management consultant, an adjunct professor and has led a niche medical society.
Michelle earned her bachelor’s and master’s degrees from Florida State University. She also has a Doctorate of Public Health in Epidemiology and Biostatistics from Florida A&M University.